Pfizer is an attractive value play, trading at a significant discount despite strong profitability and growth fundamentals ...

Pfizer faces several headwinds, including patent cliffs, regulatory risks, and a setback in obesity drug development. Click ...

Pfizer’s stock surged up to 11 percent after the pharma giant reported a robust 85 percent year-on-year rise in net profit ...

There are instances where high-yielding stocks can simply be great deals. Three stocks that pay at least 6% and don't look ...

Pfizer Inc. (NYSE:PFE) has unveiled major advances in cancer research at the 2025 ASCO Annual Meeting, spotlighting robust ...

Pfizer's stock declined over 50% due to reduced sales ... The remarkable improvement was driven by the strong performance of Pfizer's core portfolio, particularly its drugs that treat cancer ...

On May 21, analyst Geoff Meacham of Citi maintained a Hold rating on Pfizer Inc. (NYSE:PFE), reiterating the price target of ...

These four quality stocks trading at or near their 52-week lows come with stellar dividends that could be massive bargains ...

The stock's fall snapped a four-day winning streak.

Gujarat Gas Limited, Quess Corp, Power Finance Corporation, and Eris Lifesciences Limited will also report their quarterly ...